Two Years Versus Six Months of Oral Anticoagulation after a First Episode of Unprovoked Pulmonary Embolism: The Padis PE Multicenter, Double-Blind, Randomized Trial

被引：0

作者：

Couturaud, Francis ^{[1
]}

Sanchez, Olivier ^{[2
]}

Pernod, Gilles ^{[3
]}

Mismetti, Patrick ^{[4
]}

Jego, Patrick ^{[5
]}

Duhamel, Elisabeth ^{[6
]}

Provost, Karine ^{[7
]}

Sollier, Claire Bal Dit ^{[8
]}

Presles, Emilie ^{[4
]}

Castellant, Philippe ^{[9
]}

Parent, Florence ^{[10
]}

Salaun, Pierre-Yves ^{[11
]}

Bressollette, Luc ^{[11
]}

Nonent, Michel ^{[11
]}

Lorillon, Philippe ^{[12
]}

Girard, Philippe ^{[13
]}

Lacut, Karine ^{[14
]}

Guegan, Marie ^{[15
]}

Bosson, Jean-Luc ^{[16
]}

Laporte, Silvy ^{[4
]}

Leroyer, Christophe ^{[14
]}

Decousus, Herve ^{[17
]}

Meyer, Guy ^{[2
]}

Mottier, Dominique ^{[14
]}

机构：

[1] CHU Brest, Brest Univ Hosp Ctr, GIRC Thrombose, EA GETBO 3878,CIC INSERM 1412, Brest, France

[2] Georges Pompidou European Hosp, Paris, France

[3] Grenoble Univ Hosp Ctr, TIMC IMAG UMR 5525, Themas, GIRC Thrombose, Grenoble, France

[4] Univ St Etienne Ctr Hosp, EA3065, GIRC Thrombose,Clin Res Unit, St Etienne, France

[5] Rennes Univ Hosp Ctr, Rennes, France

[6] St Brieuc Gen Hosp Ctr, St Brieuc, France

[7] Lann Gen Hosp Ctr, Lannion, France

[8] Ctr Hosp Univ Lariboisiere, Paris, France

[9] Brest Univ Hosp, EA4324, Brest, France

[10] Kremlin Bicetre Univ Hosp Ctr, INSERM 999, GIRC Thrombose, Le Kremlin Bicetre, France

[11] Brest Univ Hosp Ctr, GET BO, EA 3878, Brest, France

[12] Univ Bretagne Occidentale, Ctr Hosp Univ Brest, Brest, France

[13] Inst Mutualiste Montsouris, GIRC Thrombose, Paris, France

[14] Brest Univ Hosp Ctr, EA GET BO 3878, CIC INSERM 1412, GIRC Thrombose, Brest, France

[15] Brest Univ Hosp Ctr, EA GET BO 3878, GIRC Thrombose, Brest, France

[16] Grenoble Univ Hosp Ctr, Grenoble, France

[17] St Etienne Univ Hosp Ctr, EA3065, GIRC Thrombose, St Etienne, France

来源：

BLOOD | 2014年 / 124卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[1] Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism The PADIS-PE Randomized Clinical Trial
Couturaud, Francis
Sanchez, Olivier
Pernod, Gilles
Mismetti, Patrick
Jego, Patrick
Duhamel, Elisabeth
Provost, Karine
Sollier, Claire Bal Dit
Presles, Emilie
Castellant, Philippe
Parent, Florence
Salaun, Pierre-Yves
Bressollette, Luc
Nonent, Michel
Lorillon, Philippe
Girard, Philippe
Lacut, Karine
Guegan, Marie
Bosson, Jean-Luc
Laporte, Silvy
Leroyer, Christophe
Decousus, Herve
Meyer, Guy
Mottier, Dominique
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (01): : 31 - 40
[2] Risk factors of recurrent venous thromboembolism in patients with a first episode of unprovoked pulmonary embolism: results from the PADIS PE multicenter, double-blind, randomized trial
Couturaud, F.
Sanchez, O.
Presles, E.
Salaun, P. Y.
Pernod, G.
Mismetti, P.
Jego, P.
Duhamel, E.
Provost, K.
Solier, C. B. D.
Castellant, P.
Parent, F.
Bressollette, L.
Girard, P.
Lacut, K.
Melac, S.
Guegan, M.
Laporte, S.
Leroyer, C.
Decousus, H.
Meyer, G.
Mottier, D.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 151 - +
[3] Six months versus two years of oral anticoagulation after a first episode of unprovoked deep-vein thrombosis. The PADIS-DVT randomized clinical trial
Couturaud, Francis
Pernod, Gilles
Presles, Emilie
Duhamel, Elisabeth
Jego, Patrick
Provost, Karine
Pan-Petesch, Brigitte
Sollier, Claire Bal Dit
Tromeur, Cecile
Hoffmann, Clement
Bressollette, Luc
Lorillon, Philippe
Girard, Philippe
Le Moigne, Emmanuelle
Le Hir, Aurelia
Guegan, Marie
Laporte, Silvy
Mismetti, Patrick
Lacut, Karine
Bosson, Jean-Luc
Bertoletti, Laurent
Sanchez, Oliver
Meyer, Guy
Leroyer, Christophe
Mottier, Dominique
HAEMATOLOGICA, 2019, 104 (07) : 1493 - 1501
[4] Risk factors of residual perfusion defects after a first episode of unprovoked PE: results from the PADIS PE multicenter, double-blind, randomized trial
Sanchez, O.
Tromeur, C.
Leroux, P. Y.
Presles, E.
Mismetti, P.
Jego, P.
Pernod, G.
Duhamel, E.
Provost, K.
Castellant, P.
Parent, F.
Salaun, P. Y.
Nonent, M.
Girard, P.
Lacut, K.
Melac, S.
Guegan, M.
le Marhic, G.
Laporte, S.
Leroyer, C.
Decousus, H.
Mottier, D.
Meyer, G.
Couturaud, F.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 150 - 150
[5] Risk of recurrent venous thromboembolism in patients with a first episode of unprovoked pulmonary embolism: a pre-specified subgroup analysis from the padis pe randomized trial
Couturaud, F.
Sanchez, O.
Pernod, G.
Mismetti, P.
Jego, P.
Duhamel, E.
Provost, K.
Sollier, Dit C. B.
Presles, E.
Castellant, P.
Parent, F.
Salaun, P. Y.
Bressollette, L.
Nonent, M.
Lorillon, P.
Girard, P.
Lacut, K.
Guegan, M.
Bosson, J. L.
Laporte, S.
Leroyer, C.
Decousus, H.
Meyer, G.
Mottier, D.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 989 - 989
[6] Prolongation of oral anticoagulant treatment for eighteen months versus placebo at the decline of a first episode of idiopathic pulmonary embolism treated for six months: A randomised, multicentric, double blind trial. 2006 National PHRC (Hospital clinical research programme): "PADIS-EP/Prolongation of anticoagulant treatment for 18 months for a first episode of PE initially treated for 6 months"
Couturaud, F.
REVUE DE PNEUMOLOGIE CLINIQUE, 2008, 64 (06) : 332 - 336
[7] Prolongation of anti vitamin K treatment for 18 months versus placebo after 6 months treatment of a first episode of ideopathic pulmonary embolism: a mutlicentre, randomised double blind trail. The PADIS-EP Trial
Couturaud, F.
Pernod, G.
Pison, C.
Mismetti, P.
Sanchez, O.
Meyer, G.
Parent, F.
Girard, P.
Simonneau, G.
Drouet, L.
Gueret, P.
Jego, P.
Delaval, P.
Duhamel, E.
Gruel, Y.
Delahousse, B.
Regina, S.
Pottier, P.
Connaud, J.
Lecomte, F.
Provost, K.
Vilmans, N.
Gosset, X.
Bura-Riviere, A.
Meach, G.
Lacut, K.
Bosson, J. -L.
Guillot, K.
Mottier, D.
Leroyer, C.
REVUE DES MALADIES RESPIRATOIRES, 2008, 25 (07) : 885 - 893
[8] Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial
Kline, J. A.
Nordenholz, K. E.
Courtney, D. M.
Kabrhel, C.
Jones, A. E.
Rondina, M. T.
Diercks, D. B.
Klinger, J. R.
Hernandez, J.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (04) : 459 - 468
[9] Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection - Results of an international, multicenter, double-blind, randomized clinical trial
Fife, KH
Barbarash, RA
Rudolph, T
Degregorio, B
Roth, R
Cameron, WB
Stevens, S
Tyring, S
Lappin, M
Yockey, C
Hanson, M
Long, B
Snyder, F
Raffanti, S
Nelson, M
Tipton, N
Britton, T
Collins, R
Gontero, E
Geil, J
Wright, B
DavidBajar, K
Handsfield, H
Griffith, S
Davis, R
Lalonde, J
Wright, L
McCracken, C
Waddell, R
Patel, R
Minns, G
Briefer, C
Child, D
Kelsey, J
Woolley, P
Snow, R
Garland, S
Curless, E
Thatcher, S
Guill, M
Havlichek, D
Goh, B
Luzzi, G
Wood, P
Reza, L
Stabler, C
Katz, D
Grant, D
Campbell, J
Sedlacek, T
SEXUALLY TRANSMITTED DISEASES, 1997, 24 (08) : 481 - 486
[10] Topical Versus Oral Metronidazole After Excisional Hemorrhoidectomy: A Double-Blind Randomized Controlled Trial
Xia, Weisi
Barazanchi, Ahmed W. H.
MacFater, Wiremu S.
MacCormick, Andrew D.
Svirskis, Darren
Sammour, Tarik
Hill, Andrew G.
DISEASES OF THE COLON & RECTUM, 2022, 65 (11) : 1362 - 1372

← 1 2 3 4 5 →